|
||||||||||
|
General |
||||||||||
| Clinical Use: | Peripheral nervous system disease specifically associated with the clinical spectrum of acquired neuromyotonia (NMT) and cramp-fasciculation syndrome (CFS), and disorders of the central nervous system, including Morvan syndrome, epilepsy and limbic encephalitis (LE). | |||||||||
| Availability: | Samples are batched and tested once a week. | |||||||||
| Aliases/Synonyms: | Anti-CASPR2 Autoantibody, Anti-LG1 Autoantibody, Anti-VGKC Autoantibody, CASPR2 Autoantibody, Hippocampal Autoantibody, LG1 Autoantibody, VGKC Autoantibody, Voltage Gated Potassium Channel Antibody, | |||||||||
| Code: | VGPCS | |||||||||
| Handling Instructions (to laboratory): | Send sample chilled. | |||||||||
| Hyperlink: | https://pathwest.health.wa.gov.au/~/media/PathWest/Documents/Our-Services/Clinical-Services/Immunology/Testing-for-Neuroimmunology-Conditions-at-PathWest-Laboratory-Medicine.pdf | |||||||||
| Reference Interval: |
<85 pmol/L |
|||||||||
|
Collection Requirements |
||||||||||
| Container: | Serum Sep. Tube-SST (GOLD), | |||||||||
| Sample Type: | See container | |||||||||
| Minimum Collection Volume: | 5mL | |||||||||
| Collection Instructions: | ||||||||||
|
Processing Requirements |
||||||||||
| Alternate Containers: |
|
|||||||||
| Processing Instructions: | ||||||||||
| Minimum Assay Volume: | 50uL | |||||||||
| Stability: | 2 weeks chilled | |||||||||
| Transport Instructions (to testing laboratory): | Send sample chilled. | |||||||||
|
Testing Locations |
||||||||||
| Performed at: |
|
|||||||||
|
Last Updated : 04-03-2026 14:01 |
||||||||||